Skip to main content
. 2015 Aug 18;29(4):458–463. doi: 10.1093/ajh/hpv135

Table 2.

The clinical characteristics in the patients stratified by flow-mediated vasodilation

1st quartile 2nd quartile 3rd quartile 4th quartile P value
Number 12 13 12 13
%FMD (%) 7.3±1.4 4.7±0.3** 3.3±0.4**,† 1.5±0.9**,‡,§ <0.001
Age (years) 57±15 59±12 61±10 57±16 0.87
BMI (kg/cm2) 25.0±6.2 27.0±4.9 28.2±4.3 27.8±4.7 0.43
Smoking (N [%]) 3 [25] 6 [46] 3 [25] 4 [31] 0.63
Hypertension (N [%]) 6 [50] 5 [39] 9 [75] 11 [85] 0.06
Diabetes mellitus (N [%]) 3 [25] 2 [15] 4 [33] 7 [54] 0.19
Dyslipidemia (N [%]) 2 [17] 5 [39] 2 [17] 6 [46] 0.25
ARB (N [%]) 1 [8] 1 [8] 1 [8] 5 [38] 0.09
ACE-I (N [%]) 1 [8] 0 [0] 0 [0] 1 [8] 0.55
Ca channel blocker (N [%]) 1 [8] 1 [8] 0 [0] 4 [31] 0.10
AHI (/hour) 49.3±24.6 41.3±21.2 50.0±23.9 38.7±20.9 0.51
OAI (/hour) 24.6±26.1 13.4±10.6 18.3±25.2 8.4±8.8 0.19
CAI (/hour) 0.6±0.7 1.1±1.7 2.3±5.4 0.4±1.0 0.36
HI (/hour) 22.0±12.7 23.7±16.2 26.5±16.1 29.1±16.4 0.67
TST (minute) 347±80 425±103 373±55 418±60 0.04
3%ODI (/hour) 33.3±21.0 27.2±13.4 43.7±21.9 30.5±20.9 0.19
Averaged SpO2 (%) 94.5±1.8 94.5±1.8 93.2±1.6 93.9±1.7 0.22
Lowest SpO2 (%) 73.7±11.5 77.4±7.7 75.5±8.1 73.0±11.0 0.66
SpO2 < 90% (%) 7.9±10.2 6.7±6.9 9.5±10.4 8.3±9.1 0.90
TDS (% × hour) 30.6±6.8 38.4±11.8 43.2±10.7* 42.8±12.1* 0.02

Abbreviations: FMD, flow-mediated vasodilation; BMI, body mass index; ARB, angiotensin receptor blocker; ACE-I, angiotensin-converting enzyme inhibitor; Ca, calcium; AHI, apnea-hypopnea index; OAI, obstructive apnea index; CAI, central apnea index; HI, hypopnea index; TST, total sleep time; ODI, oxygen desaturation index; SpO2, arterial oxygen saturation; TDS, time desaturation summation index.

*vs. 1st quartile group, P < 0.05. vs. 2nd quartile group, P < 0.01. **vs. 1st quartile group, P < 0.001. vs. 2nd quartile group, P < 0.001. §vs. 3rd quartile group, P < 0.001.